EDAP TMS Information

EDAP TMS is a recognized leader in robotic energy-based therapies. EDAP TMS develops, manufactures, promotes and distributes minimally invasive devices for various conditions using ultrasound technology. By combining the latest advancements in imaging, robotics, and the precise, non-invasive delivery of energy, EDAP TMS introduced the Focal One® in Europe and the United States as the leading focal therapy tool for the prostate, with the potential to expand to multiple indications beyond prostate cancer. EDAP TMS is listed on NASDAQ market in New York under ticker symbol “EDAP”.